Roman physicians recognized as early as 200 AD that women often have benign tumors in the walls of their uterus. Today, experts estimate that by age 50, some 70 percent of white women and more than 80 ...

HSG testing is a common practice in the fertility world. Why don’t women know what they’re actually getting into? WITH MY ...

HSG testing is a common practice in the fertility world. But many women aren't prepared for the pain. Doctors break it down, ...

Suze Lopez, a 41-year-old nurse who lives in Bakersfield, California, didn't know she was pregnant with her second child ...

She was shocked to be diagnosed with rectal cancer at 29 and had her reproductive organs temporarily moved out of her pelvis to be able to become pregnant after treatment.

President Trump’s off-the-cuff disclosure that he underwent an MRI scan is raising fresh questions about the secrecy surrounding Trump’s health and the need for presidents to be more transparent.

Researchers have revealed a surprising new side effect linked to GLP-1 agonists, such as Ozempic, Wegovy, Mounjaro and Zepbound. These popular treatments for diabetes and obesity could interfere with ...

A group of Black women lawmakers is leading a new effort to address the racial disparities surrounding uterine fibroids and uterine cancer. On Tuesday, Senators Lisa Blunt Rochester and Angela ...

The projections come as data shows increases in uterine cancer cases and deaths. Uterine cancer cases in the U.S. will rise significantly by 2050, with Black women three times more likely to die from ...

Please provide your email address to receive an email when new articles are posted on . Both incidence and mortality rates for uterine cancer are expected to increase through 2050. Black women will ...

Sometimes, you may need to turn a physical document into a digital file, either to keep a copy on your computer or send it to someone via email. If you have an all-in-one or multi-function printer, ...

Genmab has shared the first data on rinatabart sesutecan (Rina-S) in advanced endometrial cancer. The biotech reported a 50% unconfirmed response rate, beating the expectations of William Blair ...